Elshenawy, O.H.; Shoieb, S.M.; Mohamed, A.; El-Kadi, A.O.S.
Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target. Pharmaceutics 2017, 9, 9.
https://doi.org/10.3390/pharmaceutics9010009
AMA Style
Elshenawy OH, Shoieb SM, Mohamed A, El-Kadi AOS.
Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target. Pharmaceutics. 2017; 9(1):9.
https://doi.org/10.3390/pharmaceutics9010009
Chicago/Turabian Style
Elshenawy, Osama H., Sherif M. Shoieb, Anwar Mohamed, and Ayman O.S. El-Kadi.
2017. "Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target" Pharmaceutics 9, no. 1: 9.
https://doi.org/10.3390/pharmaceutics9010009
APA Style
Elshenawy, O. H., Shoieb, S. M., Mohamed, A., & El-Kadi, A. O. S.
(2017). Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target. Pharmaceutics, 9(1), 9.
https://doi.org/10.3390/pharmaceutics9010009